IBRXImmunityBio, Inc.

$8.30

What is the market doing?

What the tape says about IBRX

ImmunityBio, Inc. is +242% over the past year while the S&P 500 is +20%: 221 points ahead of the market.

+242%

1-year return · S&P 500 +20%

vs 200-day average
+33%

vs 200-day average · a clear uptrend

RSI (14)
57

RSI (14) · neutral

Below its 52-week high
28%

Below its 52-week high

2024-08-15$1.89 – $11.55 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$8.30
1 monthS&P 500 −0.30%
+14%
1 yearS&P 500 +20%
+242%
5 yearsS&P 500 +85%
−26%
vs 50-day average$7.59
+9.4%
52-week high
$11.55
52-week low
$1.98
Annualised volatility
102%
Calendar-year price return
YearReturn
2026 (year to date)+319%
2025−23%
2024−49%
2023−0.99%
2022−17%
2021−54%
2020+252%
2019+227%
2018−74%
2017−22%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10+28%
Feb106 of 10+12%
Mar102 of 10−12%
Apr104 of 10+1.3%
May105 of 10+6.8%
Jun104 of 10+15%
Jul114 of 11−3.6%
Aug114 of 11−5.7%
Sep115 of 11+0.06%
Oct104 of 10+2.9%
Nov106 of 10+9.7%
Dec103 of 10+4.8%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.